You are viewing: Europe Endoscopic Submucosal Dissection/ESD Market analysis

The Europe Endoscopic Submucosal Dissection/ESD Market was valued at $131.6 Million in 2025 and projected to reach to $203.1 Million by 2030, representing a compound annual growth rate of 9.1%. Europe's Endoscopic Submucosal Dissection market is poised for sustained expansion through 2030, driven by increasing prevalence of gastrointestinal cancers, rising adoption of minimally invasive procedures, and strong healthcare reimbursement policies.

Europe Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This represents a compound annual growth rate of 9.1%, significantly outpacing global trends.
  • Europe's advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong regulatory frameworks are driving market penetration across gastroenterology centers and hospitals throughout the region. The European ESD market benefits from increasing prevalence of early-stage gastrointestinal cancers, rising patient awareness, and continuous technological innovations in endoscopic equipment.
  • Europe's aging population and emphasis on precision medicine further accelerate demand for ESD procedures as a preferred treatment modality.
  • Between 2025 and 2030, Europe is expected to consolidate its position as a leading market for advanced endoscopic interventions, supported by reimbursement policies and clinical evidence supporting ESD efficacy. Key European markets including Germany, France, Italy, and the United Kingdom are driving growth through improved training programs, increased procedural volumes, and integration of ESD into standard clinical pathways.
  • Europe's commitment to healthcare innovation and patient outcomes positions the region for sustained market expansion throughout the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 9.1% CAGR
  • Market Size, 2025 ~USD 131.6 Million
  • Forecast, 2030 ~USD 203.1 Million
  • Geography Europe

Europe Endoscopic Submucosal Dissection/ESD Market Overview

Market Leadership Position :

Europe commands a significant share of the global ESD market, valued at $131.6 million in 2025 with a 9.1% CAGR, outperforming the global growth rate of 8.4% and demonstrating strong regional demand.

Advanced Healthcare Infrastructure :

Europe's sophisticated medical systems, high healthcare spending, and early adoption of minimally invasive technologies create an ideal environment for ESD procedure expansion and innovation.

Strong Regulatory Framework :

Stringent European regulatory standards and CE marking requirements ensure high-quality ESD devices and procedures, building clinician and patient confidence in treatment outcomes.

Forecast Growth Trajectory :

The European ESD market is projected to reach $203.1 million by 2030, representing a 54% increase from 2025 and indicating sustained investment in endoscopic technologies across the region.

Europe Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The region's aging population and advanced medical infrastructure support higher procedure volumes and technology adoption rates compared to global averages. Key growth catalysts include expanding training programs for ESD specialists, increasing hospital investments in endoscopic equipment, and growing patient awareness of minimally invasive treatment options.
  • European healthcare systems' emphasis on cost-effective, curative procedures positions ESD as a preferred treatment modality, ensuring robust market momentum through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Europe's ESD market is valued at $131.6 million in 2025 and will grow to $203.1 million by 2030, representing a 9.1% CAGR.
    • Europe's advanced healthcare infrastructure and strong regulatory frameworks support widespread adoption of minimally invasive ESD procedures.
    • Rising prevalence of early-stage gastrointestinal cancers and an aging population drive demand for ESD across European healthcare systems.
    • Key European markets including Germany, France, Italy, and the UK are leading growth through enhanced training and clinical integration of ESD.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Europe Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS3.463.734.154.534.995.496.036.639.8
    HOSPITALS13.0514.1615.8117.3119.1621.1823.3525.7910.3
    OTHER END USERS0.430.460.50.540.590.640.690.758.5
    SPECIALTY CLINICS4.464.815.335.86.376.997.658.399.5
    TOTAL21.423.1525.7928.1831.134.337.7341.5710

    EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS18.219.521.523.325.427.730.232.98.9
    HOSPITALS67.572.680.387.295.7104.9114.7125.69.3
    OTHER END USERS2.52.72.93.13.43.63.94.27.5
    SPECIALTY CLINICS22.824.426.828.931.534.337.240.48.6
    TOTAL111.1119.2131.6142.5156170.5185.9203.19.1

    Target Audience

    • Medical Device Manufacturers : Identify market opportunities, competitive positioning, and growth potential in Europe's high-value ESD device market to guide product development and commercialization strategies.
    • Healthcare Investors & PE Firms : Evaluate investment opportunities in European ESD companies and healthcare providers with detailed market sizing, growth forecasts, and regional profitability analysis.
    • Hospital & Clinic Administrators : Plan capital expenditures and procedure expansion strategies using market data on ESD adoption rates, reimbursement trends, and competitive offerings across European healthcare systems.
    • Market Consultants & Analysts : Support client advisory work with comprehensive European market intelligence, country-level data, and competitive insights for healthcare strategy and market entry planning.
    • Regulatory & Policy Bodies : Understand market dynamics and healthcare technology adoption patterns to inform evidence-based policy decisions and regulatory frameworks for endoscopic procedures across Europe.

    Key Companies in the Europe Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 160.7 Million · 8.8% wtd CAGR ·
    Asia Pacific
    ~USD 334.7 Million · 7.7% wtd CAGR ·
    Middle East & Africa
    ~USD 11.6 Million · 9.9% wtd CAGR ·
    Latin America
    ~USD 33.4 Million · 8.3% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 23.5 Million
    FranceUSD 17.5 Million
    UKUSD 11.8 Million
    ItalyUSD 14.5 Million
    SpainUSD 7.6 Million
    Rest Of EuropeUSD 41.6 Million

    Country market size visualization

    Germany
    USD 23.5 Million
    France
    USD 17.5 Million
    UK
    USD 11.8 Million
    Italy
    USD 14.5 Million
    Spain
    USD 7.6 Million
    Rest Of Europe
    USD 41.6 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for Europe ($131.6M in 2025) and country-level breakdowns including Germany, France, UK, and Italy, with detailed 2030 projections to support strategic planning.
    • Competitive Landscape Analysis : Understand key European players, market share distribution, and competitive positioning within the region's advanced healthcare ecosystem to identify partnership and investment opportunities.
    • Growth Driver Identification : Access in-depth analysis of Europe-specific factors including regulatory environment, reimbursement policies, healthcare spending trends, and adoption rates of minimally invasive procedures.
    • Country-Level Intelligence : Leverage granular data across major European markets (Germany: $23.5M, France: $17.5M, Italy: $14.5M, UK: $11.8M) to prioritize market entry and expansion strategies.
    • Strategic Decision Support : Make informed decisions on product launches, market expansion, and resource allocation based on Europe's 9.1% CAGR outperformance and strong healthcare infrastructure advantages.

    Frequently asked questions

    What is the current market size of ESD in Europe?

    Europe's ESD market is valued at $131.6 million in 2025 and is projected to reach $203.1 million by 2030.

    What is the growth rate of the ESD market in Europe?

    Europe's ESD market is growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2030.

    Which European countries are driving ESD market growth?

    Germany, France, Italy, and the United Kingdom are the primary drivers of ESD market growth in Europe through advanced healthcare infrastructure and clinical adoption.

    What factors are contributing to ESD market expansion in Europe?

    Key drivers include rising prevalence of early-stage gastrointestinal cancers, an aging population, technological innovations, strong reimbursement policies, and increased procedural training across Europe.

    How does Europe's ESD market compare to global trends?

    Europe's 9.1% CAGR significantly outpaces the global ESD market CAGR of 8.4%, reflecting Europe's advanced healthcare systems and higher adoption rates.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status